Kidney Transplant in the Elderly. Robert Santella, M.D., F.A.C.P.
|
|
- Arabella Hunt
- 5 years ago
- Views:
Transcription
1 Kidney Transplant in the Elderly! Robert Santella, M.D., F.A.C.P.
2 Incident Rate of ESRD by Age Age From US Renal Data System, 2012
3 Should there be an age limit? Various guidelines: Canadian, UK, AST! Consistent theme is that chronologic age is less important than physiologic age and the nature and severity of coexisting conditions! Transplant candidates should have reasonable probability of surviving beyond current waiting times for transplantation! Elderly patients should be screened more aggressively! Note that the definition of elderly has shown an upward trend over time
4 Chronologic versus Physiologic Age
5 Proportion of Dialysis Patients Wait Listed Decreases With Age 250, ,000 Prevalent ESRD Wait Listed Patients 150, ,000 50, % 21% 11% 3.4% 0.5% >79 From US Renal Data System, 2012
6 a ( ) a ( ) b ( ) (ns) ( ) Renal Transplantation in Patients Over a ( ) a ( ) a ( ) a ( ) a ( ) a ( ) Survival is lower in the transplant group for almost 2 years (time to equal survival),! but thereafter greater in the wait list group. FIGURE 2. Cumulative survival curves for elderly deceased donor transplant recipients and elderly wait-listed dialysis patients. Rao, et al. Transplantation April 27, 2007
7 Early Risk of Death in Elderly Kidney Transplant Recipients (patients over age 65) Living! Donor! SCD ECD Death Rate per 100 ptyrs in first year Days to Equal Survival Death Rate per 100 ptyrs in first year Days to Equal Survival Death Rate per 100 pt-yrs in first year Days to Equal Survival Low CV Risk Medium CV Risk High CV Risk Survival is lower with lower quality donor and with greater CV risk Gill, et al. Am J Transplantation, 2013
8 Renal Transplantation in Patients Over 70 TABLE 3. Unadjusted graft survival among deceased donor and living donor kidney transplant recipients at 1, 2, and 3 years Transplant type Transplant recipients Graft survival, including death as an event (95% CI) N % 1 yr 2 yr 3 yr Deceased donor ( ) 73.9 ( ) 66.9 ( ) Living donor ( ) 84.2 ( ) 79.3 ( ) Rao, et al. Transplantation April 27, 2007
9 Death Rates and Relative Mortality for Deceased Donor Kidney Transplant Recipients vs. Wait-Listed Patients Lippincott Williams & Wilkins Rao et al. TABLE 2. Unadjusted death rates and adjusted relative mortality risk for first deceased donor transplant recip versus wait-listed dialysis patients older than 70 years of age, Group Deaths per 100 patient years at risk (unadjusted) Wait-listed patients Deceased donor transplant Overall mortality RR compared with wait-listed patients 95% All (age 70 yr) a (0 Age yr a (0 Age 75 yr b (0 Glomerulonephritis (ns) (0 Diabetes a (0 Hypertension a (0 Other ESRD cause a (0 Rao, Short et al. Transplantation wait OPO: 700 dapril 27, a (0 Medium wait OPO: d a (0 Long wait OPO: 1350 d a (0 a P b P 0.05.
10 Age is the Major Predictor of Graft Failure Faravardek, et, al. Transplantation 2013
11 Projected Life Expectancy After ESRD Onset: Effect of Time on Dialysis Schold, et al. Clin J Am Soc Neph 2006
12 Quality of Life in Older Kidney Transplant Recipients KTx recipient years National norm KTx recipient 65 years National norm SF Score SF Score PF RP BP GH VT SF RE MH 0 PF RP BP GH VT SF RE MH PF=physical functioning, RP=limitation due to health, BP=body pain, GH=general health,! VT=vitality, SH=social functioning, RE=emotional role, MH=mental health!! Humar, et al. Experimental and Clinical Transplantation, 2003
13 Cost Effectiveness of Kidney Transplant in the Elderly In the general ESRD population kidney transplant is highly cost effective! In the elderly:! living donor transplantation is cost effective! deceased donor transplantation is economically attractive if < 2 year wait and variable with a 2-4 year wait! deceased donor kidney transplantation is not cost effective if wait time is extended 4 years
14 Outcomes of Transplants From Older Living Donors to Older Recipients: Recipient Outcomes Table 3. Transplant Outcomes by Donor Type OLD YLD ECD SCD P No. 1,133 5,873 4,551 12,197 DGF (%) Primary nonfunction (%) Acute rejection (%) At discharge At 1 y Mean SCr 1 y posttransplantation (mg/dl) SCr 1.5 mg/dl at 1 y posttransplantation (%) Mean egfr at 1 y posttransplantation (ml/min/1.73 m 2 ) Note: Serum creatinine in mg/dl may be converted to DGF = delayed graft function! OLD = older living donor (>55 mean age = 61)! YLD = younger living donor (<55, mean age = 39)! ECD = expanded criteria donor! SCD = standard criteria donor mol/l by multiplying by 88.4; egfr in ml/min/1.73 m 2 may be Gill, et al. AJKD 2008
15 larly given their poor outcomes while on the Figure 2. Patient survival by donor type. Abb tions: OLD, older living donor; YLD, younger living transplant wait list.3 During the study period ECD, expanded criteria deceased donor; SCD, sta 1996 to 2005, a total of 30% of recipients older criteria deceased donor. Outcomes of Transplants From Older Living Donors than 60 years underwent living donor transplantation (17% from donors! 55Recipients: years). This Recipient donor transplantations to Older Outcomes in the elderly and a represents a growing trend of increased living creasing trend to use organs from OLDs. Here, we show that recipients ofgilltransp et al Graft Survival Patient Survival from OLDs (defined as donor age! 55 y had superior allograft and patient survival for reoperation or readmission to the hospipared with recipients of both SCD and ostoperative hypertension, and other unspecitransplants. Recipients of transplants from O omplications. Of 253 OLDs, 244 (96.4%) had lower rates of delayed graft function o reported acute complications. By comparimary nonfunction, and acute rejection comp of 1,331 YLDs, 1,294 (97.2%) had no rewith recipients of ECD transplants. Alth d acute complications. Of those with rerecipients of transplants from OLDs had gr d complications, there were no significant SCr levels at 1 year posttransplantation ences between OLDs and YLDs. pared with recipients of transplants from Y and SCDs, they had superior renal function DISCUSSION pared with recipients of ECD transplants. e long wait times for kidney transplants These results are in keeping with pre a significant impact on the elderly, particusingle-center and retrospective studies exa given their poor outcomes while on the Figure 2. Patient survival by donor type. Abbreviations: OLD, older living donor; YLD, younger living donor; plant wait list.3 During the study period ECD, expanded criteria deceased donor; SCD, standard to 2005, a total of 30% of recipients older criteria deceased donor. Gill, et al. AJKD years underwent living donor transplan(17% from donors! 55 years). This
16 Outcomes of Transplants From Older Living Donors to Older Recipients: Donor Outcomes Post donation estimated GFR Donors <60 Post donation estimated GFR Donors > donors, ! Percent decline in GFR was not different between older and younger donors. Older donors had lower GFR pre-donation! No difference in donor survival Dols, et al. Am J Transplantation 2011
17 Older Kidney Donors Older donors have similar outcomes to younger donors: operative time, blood loss, length of stay, complications, change in GFR.! Older donors are less likely than younger donors to have enough time for risk factors, such as HTN, to lead to kidney disease.! OPTN (Organ Procurement & Transplantation Network) data show that most donors who develop renal failure and are placed on the recipient wait list are between years and developed ESRD >15 years after donation.
18 Cumulative time on the wait-list (yr) PRA, panel reactive antibody. Probability of Transplantation: Effect of Wait Time Table 6. Probability of death on the wait-list or removal from the wait-list by age and race Recipient Age (yr) Race Cumulative time on the wait-list (yr) $60 White Black Other White Black Other White Black Other White Black Other Chang, et al. CJASN 2012
19 Half of Kidney Transplant Candidates Older than 60 Placed on the Waiting List Will Die before Receiving a deceased Donor Transplant Table 1. Proportion of older candidates who received a deceased-donor transplant and proportion of patient deaths at 5 yr after listing (1995 through 2007) a Patient Characteristic Level (%) 5-yr Probability of DDTx (%) b 5-yr Probability of Mortality (%) c Age 60 to 64 (50) to 69 (34) Schold, et al. CJASN (17) Primary diagnosis Diabetes (37) Hypertension (20) Other (43) BMI 13 to 25 (29) Registry data: 54,669 wait listed candidates over age 60, Schold, et al. Clin J Am Soc Neph, 2009
20 Deceased vs. Living Donors in the Elderly
21 Benefit of Accepting High Infection Risk Donor Chow, et al, Am J Transplantation, 2013 Modeling of 65 yo, diabetic, 5 yrs to non-ird transplant Worst-case model: IV drug user donor (highest risk donor), assumes standard false neg rate with ELISA & 100% transmission and seroconversion from of infected donors
22 Risk of Immunosuppression in Elderly Kidney Recipients USRDS/UNOS Data Meier-Kriesche, et al. Transplantation 2000
23 Risk of Immunosuppression in Elderly Kidney Recipients Increased infection - opportunistic infectious death increased 8.7 times! Increased cancer! Decreased rejection rates, but possibly more difficult to treat rejection as chronic graft loss is higher in the elderly! Avoid lymphocyte depleting antibody induction (Campath, Thymoglobulin) which creates a dilemma in the highly HLA sensitized older recipient
24 Evaluation Issues in Elderly Transplant Candidates Conventional Factors - all increased in the elderly! Cardiac - CAD, CHF, Pulmonary HTN! Infection! Malignancy! Additional Issues Important in the Elderly! Cognitive Impairment! Functional Status! Frailty
25 Cognitive Impairment in Elderly Transplant Candidates Cognitive Impairment!! 10-30% of young and mid aged dialysis patients!! 30-55% of dialysis patients over 75 years!! Spousal support often lacking in the elderly
26 Decreased Functional Status is Associated with Death in Elderly Transplant Recipients UNOS data, >10,000 patients, SF-36 measurement data Reese, et al. Transplantation, 2013
27 Overconfidence
28 Frailty Definition - 3 or more! Unintentional weight loss (10 lbs. in 1 yr.)! Weakness (grip strength)! Slow walking speed (15 ft. in <6-7 sec)! Low physical activity! Self reported exhaustion
29 2010 Renal Physicians Association guideline on the appropriate initiation and withdrawal of dialysis (2,15) provides guidance in shared decision-making, advance care planning, prognosis evaluation, and palliative care and has been shown to be effective in improving nephrologists preparedness in EOL decision-making (16). death (2.24). Of those patients who tested positive for frailty, 27% had neither ADL disability nor comorbidity (two or more comorbidities). Additionally, those patients who were prefrail at baseline (46.6%) had an adjusted odds ratio of 2.63 of becoming frail in the next 3 4 years compared with those patients who had no frailty components (17). It must be emphasized that the operational definition of frailty varies widely according to the conceptual framework, and no gold standard exists (14,26). At what point does frailty become advanced or irreversible? Like the EOL concept (27,28), frailty can be viewed Mortality in Frail Elderly Dialysis Patients Consequences of Frailty for the Elderly Patient with Renal Disease The geriatric syndrome of frailty is a biologic wasting syndrome of older adults that spans multiple physiologic Table 1. Mean life expectancy by quartile following dialysis initiation according to age and renal phenotype Renal Phenotype Quartiles 25th Percentile (0 25; frail) 50th Percentile (25 75; vulnerable) 75th Percentile (75 100; healthy) Adapted from reference 33, with permission. Tamura, et al. Kidney Int, 2012 Life Expectancy by Age Group (yrs)
30 Frailty in Elderly Kidney Transplant Candidates Little specific data in kidney transplant population! Frailty is associated with:! Peri-operative complications! Length of stay and early readmission! Delayed graft function
31 Kidney Transplant In The Elderly: Summary Select elderly candidates likely to benefit from transplant with thoughtful individual review! Less focus on age and more attention to functional status! Predict wait time - no survival benefit beyond four years. Highly HLA sensitized elderly pose a problem! Half of all patients over 60 on the wait list will die before receiving a transplant! Best outcome = living donor! Elderly patients without living donors must consider older deceased donors and CDC high risk donors
32
The New Kidney Allocation System: What You Need to Know. Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health
The New Kidney Allocation System: What You Need to Know Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health ~6% of patients die each year on the deceased donor waiting
More informationThe Kidney Allocation System Changed in a Substantive Way on December 5, Your Patients Have Been, and Will Be, Affected by These Changes
The Kidney Allocation System Changed in a Substantive Way on December 5, 2014 Your Patients Have Been, and Will Be, Affected by These Changes 1 The New Kidney Allocation System Terms of Importance Pediatric
More informationKidney Transplant Outcomes In Elderly Patients. Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania
Kidney Transplant Outcomes In Elderly Patients Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania Case Discussion 70 year old Asian male, neuropsychiatrist, works full
More informationCardiovascular Risk Reduction in Kidney Transplant Recipients
Cardiovascular Risk Reduction in Kidney Transplant Recipients Rainer Oberbauer R.O. AUG 2010 CV Mortality in ESRD compared to the general population R.O.2/32 Modified from Foley et al. AJKD 32 (suppl3):
More informationLiterature Review: Transplantation July 2010-June 2011
Literature Review: Transplantation July 2010-June 2011 James Cooper, MD Assistant Professor, Kidney and Pancreas Transplant Program, Renal Division, UC Denver Kidney Transplant Top 10 List: July Kidney
More informationKidney Transplantation in the Elderly. Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo
Kidney Transplantation in the Elderly Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo Agenda Background: Age and chronic kidney disease End stage kidney disease:
More informationLiterature Review Transplantation
Literature Review 2010- Transplantation Alexander Wiseman, M.D. Associate Professor, Division of Renal Diseases and Hypertension Medical Director, Kidney and Pancreas Transplant Programs University of
More informationTransplant Options for Patients: Choices and Consequences. Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital
Transplant Options for Patients: Choices and Consequences Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital BC Kidney Days October 6 th 2017 Non contributory Conflict of
More informationThe New Kidney Allocation Policy: Implications for Your Patients and Your Practice
The New Kidney Allocation Policy: Implications for Your Patients and Your Practice Clinical Practice Today CME Co-provided by Learning Objectives Upon completion, participants should be able to: Explain
More informationOutcomes of Adult Dual Kidney Transplants by KDRI in the United States
American Journal of Transplantation 2013; 13: 2433 2440 Wiley Periodicals Inc. Brief Communication C Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons
More informationQuantification of the Early Risk of Death in Elderly Kidney Transplant Recipients
Wiley Periodicals Inc. C Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons Quantification of the Early Risk of Death in Elderly Kidney Transplant Recipients
More informationWho will not benefit from a kidney transplant. Deirdre Sawinski, MD University of Pennsylvania
Who will not benefit from a kidney transplant Deirdre Sawinski, MD University of Pennsylvania Disclosures No financial disclosures relevant to this presentation. I am a transplant nephrologist and I believe
More informationFor more information about how to cite these materials visit
Author(s): Silas P. Norman, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/
More informationChapter 6: Transplantation
Chapter 6: Transplantation Introduction During calendar year 2012, 17,305 kidney transplants, including kidney-alone and kidney plus at least one additional organ, were performed in the United States.
More informationScores in kidney transplantation: How can we use them?
Scores in kidney transplantation: How can we use them? Actualités Néphrologiques 2017 M Hazzan (Lille France ) Contents Scores to estimate the quality of the graft Scores to estimate old candidates to
More informationGeriatric Nephrology. Murtener Tage
Geriatric Nephrology Murtener Tage 2014 Isabelle.Binet@kssg.ch www.nierenstiftung.ch Plan Geriatric nephrology The elderly with CKD The elderly on dialysis The elderly in transplantation Plan Geriatric
More informationKidney and Pancreas Transplantation in the United States,
American Journal of Transplantation 2006; 6 (Part 2): 1153 1169 Blackwell Munksgaard No claim to original US government works Journal compilation C 2006 The American Society of Transplantation and the
More informationOlder Living Kidney Donors and Recipients. Charles Le University of Colorado 6/24/11
Older Living Kidney Donors and Recipients Charles Le University of Colorado 6/24/11 Clinical Scenario HPI: 60 y/o healthy AAM with h/o CKD5 on HD x 2 yrs 2/2 HTN, was evaluated in transplant clinic for
More informationRenal Transplant Past Present and Future David Landsberg
2012 Renal Transplant Past Present and Future David Landsberg Outline Changing pattern of Donors Types of Donors Allocation Results Challenges in the Elderly LDPE Transplants By Year LD LRD LUD NDAD DD
More informationClinical correlates, outcomes and healthcare costs associated with early mechanical ventilation after kidney transplantation
The American Journal of Surgery (2013) 206, 686-692 Association of Women Surgeons: Clinical Science Clinical correlates, outcomes and healthcare costs associated with early mechanical ventilation after
More informationLiving Donor Paired Exchange (LDPE)
Living Donor Paired Exchange (LDPE) Why do we need Living Donation? 3,796 patients waiting for an organ transplant 2,679 (71%) waiting for a kidney transplant 249 people died while waiting for an organ
More informationchapter seven transplantation page
chapter seven There been times that I thought I couldn t last for long But now I think I m able to carry on It s been a long, a long time coming But I know a change gonna come, oh yes it will Sam Cooke,
More informationDonation from Old Living Donors How safe is it? Safe for recipient or donor?
Donation from Old Living Donors How safe is it? Safe for recipient or donor? Pr Lionel Rostaing Service de Néphrologie, Hémodialyse, Aphérèses et Transplantation CHU Grenoble Alpes France lrostaing@chu-grenoble.fr
More informationUpdate on Kidney Allocation
Update on Kidney Allocation 23rd Annual Conference Association for Multicultural Affairs in Transplantation Silas P. Norman, M.D., M.P.H. Associate Professor Division of Nephrology September 23, 2015 Disclosures
More informationRenal Transplantation: Allocation challenges and changes. Renal Transplantation. The Numbers 1/13/2014
Renal Transplantation: Allocation challenges and changes Mark R. Wakefield, M.D., F.A.C.S. Associate Professor of Surgery/Urology Director Renal Transplantation Renal Transplantation Objectives: Understand
More informationOutcomes of dialysis in the elderly. DNT March 2011 Dr Céline Foote
Outcomes of dialysis in the elderly DNT March 2011 Dr Céline Foote Increasing number of elderly patients on renal replacement therapy 500 500 Patients per million 400 300 200 100 400 300 200 100 TOTAL
More informationTransplant Update New Kidney Allocation System Transplant Referral Strategies. Antonia Harford, MD University of New Mexico
Transplant Update New Kidney Allocation System Transplant Referral Strategies Antonia Harford, MD University of New Mexico Financial Disclosures Doctor Harford has received financial support for dialysis
More informationHome Hemodialysis or Transplantation of the Treatment of Choice for Elderly?
Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly? Miklos Z Molnar, MD, PhD, FEBTM, FERA, FASN Associate Professor of Medicine Division of Nephrology, Department of Medicine University
More informationAre Your Patients Well Prepared for Kidney Transplant?
Are Your Patients Well Prepared for Kidney Transplant? Venkatesh Kumar Ariyamuthu MD FASN Disclosures National Kidney Foundation Scientific Advisory Board 78 year old Hispanic female ESRD secondary to
More informationAccess and Outcomes Among Minority Transplant Patients, , with a Focus on Determinants of Kidney Graft Survival
American Journal of Transplantation 2010; 10 (Part 2): 1090 1107 Wiley Periodicals Inc. Special Feature No claim to original US government works Journal compilation C 2010 The American Society of Transplantation
More informationBack to dialysis after graft failure: Transplantectomy or not? Stop immunosuppression?
Back to dialysis after graft failure: Transplantectomy or not? Stop immunosuppression? Laurent WEEKERS CHU SartTilman Layout Introduction Epidemiology A note of caution on causality and bias Patient survival
More informationAre two better than one?
Are two better than one? Disclosures Ryutaro Hirose, MD Professor in Clinical Surgery University of California, San Francisco I have no relevant disclosures related to this presentation The PROBLEM There
More informationLong-term Non-ESRD Kidney Donor Risks. Arthur Matas Dept Surgery University of Minnesota
Long-term Non-ESRD Kidney Donor Risks Arthur Matas Dept Surgery University of Minnesota Conflict of Interest Disclosure I have no relevant financial relationships to disclose No off label use will be discussed
More informationJadranka Buturović-Ponikvar Department of Nephrology, University Medical Center, Ljubljana, Slovenia
Jadranka Buturović-Ponikvar Department of Nephrology, University Medical Center, Ljubljana, Slovenia Hemodialysis or kidney transplantation what is better? Jadranka Buturović-Ponikvar Department of Nephrology,
More informationkidney OPTN/SRTR 2012 Annual Data Report:
kidney wait list 18 deceased donation 22 live donation 24 transplant 26 donor-recipient matching 28 outcomes 3 pediatric transplant 33 Medicare data 4 transplant center maps 43 A. J. Matas1,2, J. M. Smith1,3,
More informationThree Sides to Allocation. ECD Extended Criteria Donor
Kidney Allocation- Optimal Use of Deceased Donors The New US System..and impact on wait list management Three Sides to Allocation Justice Peter G Stock MD, PhD Utility Efficiency Standard Criteria Donor
More informationPredictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
Pediatr Transplantation 2013: 17: 436 440 2013 John Wiley & Sons A/S. Pediatric Transplantation DOI: 10.1111/petr.12095 Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
More informationTransplant Nephrology Update: Focus on Outcomes and Increasing Access to Transplantation
Transplant Nephrology Update: Focus on Outcomes and Increasing Access to Transplantation Titte R Srinivas, MD, FAST Medical Director, Kidney and Pancreas Transplant Programs Objectives: Describe trends
More informationReceiving a Kidney Transplant in the Ninth Decade of Life
Trends Edmund in Transplant. Huang and 2011;5:121-7 Suphamai Bunnapradist: Receiving a Kidney Transplant in the Ninth Decade of Life Receiving a Kidney Transplant in the Ninth Decade of Life Edmund Huang
More informationLIVE KIDNEY DONOR RISK PREDICTION ; NEW PARADIGM, NEW CALCULATORS PEDRAM AHMADPOOR MD
LIVE KIDNEY DONOR RISK PREDICTION ; NEW PARADIGM, NEW CALCULATORS PEDRAM AHMADPOOR MD Outline: PART 1 : Update on safety of nephrectomy for living donor candidate PART 2 : Latest guideline recommendation
More informationExpanded Criteria Recipients: Are there any Limits
Expanded Criteria Recipients: Are there any Limits Andreas Paul, MD, MSc, FRCS Department of General-, Visceral- and Transplant Surgery, University Hospital Essen Ruhr Area 5.200 000 inhabitants University
More informationKidney Transplant. Description
Section: Surgery Effective Date: October 15, 2015 Subject: Kidney Transplant Page: 1 of 9 Last Review Status/Date: September 2015 Kidney Transplant Description A kidney transplant involves the surgical
More informationThe principal goals of kidney transplantation are to improve
Is Kidney Transplantation for Everyone? The Example of the Older Dialysis Patient Greg A. Knoll Division of Nephrology, Kidney Research Centre, and the Clinical Epidemiology Program, Ottawa Hospital Research
More informationSimultaneous Pancreas Kidney Transplantation:
Simultaneous Pancreas Kidney Transplantation: What is the added advantage, and for whom? Alexander Wiseman, M.D. Associate Professor, Division of Renal Diseases and Hypertension Medical Director, Kidney
More informationPatient Education Transplant Services. Glossary of Terms. For a kidney/pancreas transplant
Patient Education Glossary of Terms For a kidney/pancreas transplant Glossary of Terms Page 18-2 Antibody A protein substance made by the body s immune system in response to a foreign substance. Antibodies
More informationThanks to our Speakers!
Thanks to our Speakers! Fizza Naqvi, MD Assistant Professor at the Department of Medicine (Nephrology), Johns Hopkins Attending physician at Johns Hopkins hospital. Involved with kidney recipient evaluation
More informationKidney transplantation 2016: current status and potential challenges
Kidney transplantation 2016: current status and potential challenges 15/12/2016 BVN-SBN : State-of-the-Art on Kidney Transplantation Patrick Peeters Ghent University Hospital, Belgium Challenges in 2016
More informationOPTN/SRTR 2016 Annual Data Report: Preface
OPTN/SRTR 2016 Annual Data Report: Preface This Annual Data Report of the US Organ Procurement and Transplantation Network (OPTN) and the Scientific Registry of Transplant Recipients (SRTR) is the twenty-sixth
More informationCurrent status of kidney and pancreas transplantation in the United States,
American Journal of Transplantation 25; 5 (Part 2): 94 915 Blackwell Munksgaard Blackwell Munksgaard 25 Current status of kidney and pancreas transplantation in the United States, 1994 23 Gabriel M. Danovitch
More informationThe New Kidney Allocation System: What You Need to Know. Quality Insights Renal Network 3 Annual Meeting October 2, 2014
The New Kidney Allocation System: What You Need to Know Quality Insights Renal Network 3 Annual Meeting October 2, 2014 Pre Dialysis Era Dialysis Status in USA 500,000 patients on dialysis in 2013 100,000
More informationWait List Management. John J. Friedewald, Darshika Chhabra, and Baris Ata. The US Transplant System. National Wait List
Wait List Management John J. Friedewald, Darshika Chhabra, and Baris Ata 4 Abbreviations CDC Centers for Disease Control and Prevention CPRAs Calculated panel reactive antibodies DCD Donation after cardiac
More informationConcept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA
Concept and General Objectives of the Conference: Prognosis Matters Andrew S. Levey, MD Tufts Medical Center Boston, MA General Objectives Topics to discuss What are the key outcomes of CKD? What progress
More informationHeart Transplantation
Heart Transplantation Age and Outcome Mayo Clinic Richard Daly, MD Professor of Surgery Surgical Director Heart & Lung Transplantation 2014 MFMER 3346076-1 Rochester, Minnesota 2014 MFMER 3346076-2 The
More informationProspective Evaluation of the Eyeball Test for Assessing Frailty in Elderly Patients with Valvular Heart Disease
Prospective Evaluation of the Eyeball Test for Assessing Frailty in Elderly Patients with Valvular Heart Disease Background Frailty is a common occurrence in elderly patients Approximately half of the
More informationPeter Chang,* Jagbir Gill,* James Dong,* Caren Rose,* Howard Yan,* David Landsberg,* Edward H. Cole, and John S. Gill*
Article Living Donor Age and Kidney Allograft Half-Life: Implications for Living Donor Paired Exchange Programs Peter Chang,* Jagbir Gill,* James Dong,* Caren Rose,* Howard Yan,* David Landsberg,* Edward
More informationSteroid Minimization: Great Idea or Silly Move?
Steroid Minimization: Great Idea or Silly Move? Disclosures I have financial relationship(s) within the last 12 months relevant to my presentation with: Astellas Grants ** Bristol Myers Squibb Grants,
More informationDeveloping a Kidney Waiting List Calculator
Developing a Kidney Waiting List Calculator Jon J. Snyder, PhD* Nicholas Salkowski, PhD, Jiannong Liu, PhD, Kenneth Lamb, PhD, Bryn Thompson, MPH, Ajay Israni, MD, MS, and Bertram Kasiske, MD, FACP *Presenter
More informationBK virus infection in renal transplant recipients: single centre experience. Dr Wong Lok Yan Ivy
BK virus infection in renal transplant recipients: single centre experience Dr Wong Lok Yan Ivy Background BK virus nephropathy (BKVN) has emerged as an important cause of renal graft dysfunction in recent
More informationTransplantation: Year in Review
Transplantation: Year in Review Alexander Wiseman, MD Medical Director, Kidney and Pancreas Transplant Program Associate Professor, Division of Renal Diseases and Hypertension University of Colorado Outline:
More informationProgress in Pediatric Kidney Transplantation
Send Orders for Reprints to reprints@benthamscience.net The Open Urology & Nephrology Journal, 214, 7, (Suppl 2: M2) 115-122 115 Progress in Pediatric Kidney Transplantation Jodi M. Smith *,1 and Vikas
More informationA Lifetime of Allograft Function with Kidneys from Older Donors
A Lifetime of Allograft Function with Kidneys from Older Donors Caren Rose,* Elke Schaeffner, Ulrich Frei, Jagbir Gill,* and John S. Gill* *Division of Nephrology, University of British Columbia, Vancouver,
More informationOPTN/SRTR 2014 ANNUAL DATA REPORT
OPTN/SRTR 14 ANNUAL DATA REPORT KIDNEY A Hart 1, J M Smith 2,3, M A Skeans 3, S K Gustafson 3, D E Stewart 4,5, W S Cherikh 4,5, J L Wainright 4,5, G Boyle 4,5, J J Snyder 3,6, B L Kasiske 1,3, A K Israni
More informationHasan Fattah 3/19/2013
Hasan Fattah 3/19/2013 AASK trial Rational: HTN is a leading cause of (ESRD) in the US, with no known treatment to prevent progressive declines leading to ESRD. Objective: To compare the effects of 2 levels
More informationSELECTED ABSTRACTS. All (n) % 3-year GS 88% 82% 86% 85% 88% 80% % 3-year DC-GS 95% 87% 94% 89% 96% 80%
SELECTED ABSTRACTS The following are summaries of selected posters presented at the American Transplant Congress on May 5 9, 2007, in San Humar A, Gillingham KJ, Payne WD, et al. Review of >1000 kidney
More informationKidney Transplant Outcomes for Prolonged Cold Ischemic Times in the Context of Kidney Paired Donation
Kidney Transplant Outcomes for Prolonged Cold Ischemic Times in the Context of Kidney Paired Donation by Yayuk Joffres Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of Master
More informationDonor Quality Assessment
Donor Quality Assessment Francesc Moreso, MD, PhD Renal Transplant Unit Hospital Universitari Vall d Hebron Barcelona. Spain 4/9/2017 Donor Quality Assessment 1 What is the problem? Across all age ranges,
More informationA Guide to Better Living
Transplantation What Is a Kidney Transplant? Kidney transplantation is placing a kidney from one person (donor) into a patient with kidney failure (recipient). This is done by surgery where the donated
More informationDoes Kidney Donor Risk Index implementation lead to the transplantation of more and higher-quality donor kidneys?
Nephrol Dial Transplant (2017) 32: 1934 1938 doi: 10.1093/ndt/gfx257 Advance Access publication 21 August 2017 Does Kidney Donor Risk Index implementation lead to the transplantation of more and higher-quality
More informationLe migliori strategie immunosoppressive per il paziente con re-trapianto Prof. Maurizio Salvadori FIRENZE
Le migliori strategie immunosoppressive per il paziente con re-trapianto Prof. Maurizio Salvadori FIRENZE Best Therapy for Kidney Re- Transplantation? PREVENTION!!!! Registries CTS OPTN UNOS USRDS SRTR
More informationmorbidity & mortality
morbidity & mortality esrd introduction of ESRD treatment. We examine these concerns throughout the ADR, particularly in Chapter One. This year we focus on infectious complications, especially those related
More informationDesensitization in Kidney Transplant. James Cooper, MD Assistant Professor, Kidney and Pancreas Transplant Program, Renal Division, UC Denver
Desensitization in Kidney Transplant James Cooper, MD Assistant Professor, Kidney and Pancreas Transplant Program, Renal Division, UC Denver Organ Shortage Currently there are >90,000 patients on the kidney
More informationConcepts for Kidney Allocation
ORGAN PROCUREMENT AND TRANSPLANTATION NETWORK Concepts for Kidney Allocation The Organ Procurement and Transplantation Network (OPTN) is seeking feedback regarding the use of two concepts in the allocation
More informationJ Am Soc Nephrol 14: , 2003
J Am Soc Nephrol 14: 208 213, 2003 Kidney Allograft and Patient Survival in Type I Diabetic Recipients of Cadaveric Kidney Alone Versus Simultaneous Pancreas/Kidney Transplants: A Multivariate Analysis
More informationKIDNEY TRANSPLANTATION IS THE
ORIGINAL CONTRIBUTION Deceased-Donor Characteristics and the Survival Benefit of Kidney Transplantation Robert M. Merion, MD Valarie B. Ashby, MA Robert A. Wolfe, PhD Dale A. Distant, MD Tempie E. Hulbert-Shearon,
More informationNew York City Development of the Geriatric Collaborative
New York City - 2014 Development of the Geriatric Collaborative The Clinical Problem More than 50% persons age 65 years will have some surgical procedure in the remainder of his or her lifetime Outcome
More informationAnswers to Your Questions about a Change in Kidney Allocation Policy What you need to know
Answers to Your Questions about a Change in Kidney Allocation Policy What you need to know Who are UNOS and the OPTN? The United Network for Organ Sharing (UNOS) is a nonprofit organization that operates
More informationLUNG ALLOCATION SCORE SYSTEM UPDATE
LUNG ALLOCATION SCORE SYSTEM UPDATE Current Lung Allocation System System was implemented on May 4, 25 The Lung Allocation Score (LAS) is based on a combination of Expected survival in next year without
More informationNearly half of a million individuals in the United
Access to Kidney Transplantation among the Elderly in the United States: A Glass Half Full, not Half Empty Elke S. Schaeffner,* Caren Rose, and John S. Gill *Division of Nephrology, Charité University
More informationShould Pediatric Patients Wait for HLA-DR-Matched Renal Transplants?
American Journal of Transplantation 2008; 8: 2056 2061 Wiley Periodicals Inc. C 2008 The Authors Journal compilation C 2008 The American Society of Transplantation and the American Society of Transplant
More informationGlossary. Anesthesiologist A doctor who puts you or parts of your body to sleep during surgery.
1-Glossary Glossary Acute rejection A type of rejection that occurs when immune cells from your body attack the transplanted organ(s). Acute rejection may occur at any time after a transplant. But it usually
More informationDonor and Recipient Age and the Allocation of Deceased Donor Kidneys for Transplantation
Donor and Recipient Age and the Allocation of Deceased Donor Kidneys for Transplantation July 26, 2006 Donor and Recipient Age and the Allocation of Deceased Donor Kidneys for Transplantation A paper prepared
More informationShould red cells be matched for transfusions to patients listed for renal transplantation?
Should red cells be matched for transfusions to patients listed for renal transplantation? Dr M.Willicombe Imperial College Renal and Transplant Centre, Hammersmith Hospital Should red cells be matched
More informationObesity has become an epidemic in the United States
Original Clinical ScienceçGeneral Selected Mildly Obese Donors Can Be Used Safely in Simultaneous Pancreas and Kidney Transplantation Tarek Alhamad, MD, MS, 1,2 Andrew F. Malone, MD, 1 Krista L. Lentine,
More informationLas dos caras de la cretinina sérica The two sides of serum creatinine
Las dos caras de la cretinina sérica The two sides of serum creatinine ASOCIACION COSTARRICENSE DE MEDICINA INTERNA San José, Costa Rica June 2017 Kianoush B. Kashani, MD, MSc, FASN, FCCP 2013 MFMER 3322132-1
More informationKidney Allocation- Will it ever be fair? Peter G Stock MD, PhD UCSF Department of Surgery. Would you accept this offer?
Kidney Allocation- Will it ever be fair? Peter G Stock MD, PhD UCSF Department of Surgery Question 1: A 19 y/o deceased donor kidney (O mismatch) from NYC is allocated to a 72 y/o highly sensitized caucasian
More informationThe New Kidney Allocation System (KAS) Frequently Asked Questions
The New Kidney Allocation System (KAS) Frequently Asked Questions Contents General: The Need for the New System and Key Implementation Details... 4 Why was the newly revised KAS necessary?... 4 What were
More informationManagement of the Frail Older Patients: What Are the Outcomes
Management of the Frail Older Patients: What Are the Outcomes Professor Edwina Brown Imperial College Renal and Transplant Centre Hammersmith Hospital, London Increasing prevalence of old old on RRT RRT
More informationConsidering the early proactive switch from a CNI to an mtor-inhibitor (Case: Male, age 34) Josep M. Campistol
Considering the early proactive switch from a CNI to an mtor-inhibitor (Case: Male, age 34) Josep M. Campistol Patient details Name DOB ESRD Other history Mr. B.I.B. 12 January 1975 (34yo) Membranous GN
More informationA Simple Tool to Predict Outcomes After Kidney Transplant
Transplantation A Simple Tool to Predict Outcomes After Kidney Transplant Bertram L. Kasiske, MD, 1,2 Ajay K. Israni, MD, MS, 1,2,3 Jon J. Snyder, PhD, MS, 2,3 Melissa A. Skeans, MS, 2 Yi Peng, MS, 2 and
More informationThe Elderly Patient with Low egfr: Beyond a Disease-Oriented Approach. Maroun Azar, M.D.
The Elderly Patient with Low egfr: Beyond a Disease-Oriented Approach Maroun Azar, M.D. Disclosures None, no conflicts of interest Some of the Arguments Are current definitions of CKD accurate in the
More informationJames E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant
James E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant Program Has no real or apparent conflicts of interest
More informationOPTN/SRTR 2015 Annual Data Report: Deceased Organ Donation
OPTN/SRTR 2015 Annual Data Report: Deceased Organ Donation A. K. Israni 1,2,3, D. Zaun 1, C. Bolch 1, J.D. Rosendale 4,5, C. Schaffhausen 3, J. J. Snyder 1,2, and B. L. Kasiske 1,3 1 Scientific Registry
More informationGeriatrics and Cancer Care
Geriatrics and Cancer Care Roger Wong, BMSc, MD, FRCPC, FACP Postgraduate Dean of Medical Education Clinical Professor, Division of Geriatric Medicine UBC Faculty of Medicine Disclosure No competing interests
More informationThe time interval between kidney and pancreas transplantation and the clinical outcomes of pancreas after kidney transplantation
Clin Transplant 2012: 26: 403 410 DOI: 10.1111/j.1399-0012.2011.01519.x ª 2011 John Wiley & Sons A/S. The time interval between kidney and pancreas transplantation and the clinical outcomes of pancreas
More informationManagement of Rejection
Management of Rejection I have no disclosures Disclosures (relevant or otherwise) Deborah B Adey, MD Professor of Medicine University of California, San Francisco Kidney and Pancreas Transplant Center
More informationObjectives. Kidney Complications With Diabetes. Case 10/21/2015
Objectives Kidney Complications With Diabetes Brian Boerner, MD Diabetes, Endocrinology, and Metabolism University of Nebraska Medical Center Review screening for, and management of, albuminuria Review
More informationTREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009
TREAT THE KIDNEY TO SAVE THE HEART Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009 1 ESRD Prevalent Rates in 1996 per million population December
More informationDisparities in Transplantation Caution: Life is not fair.
Disparities in Transplantation Caution: Life is not fair. Tuesday October 30 th 2018 Caroline Rochon, MD, FACS Surgical Director, Kidney Transplant Program Hartford Hospital, Connecticut Outline Differences
More information